Michael Brooks
President at EDESA BIOTECH, INC.
Net worth: 78 945 $ as of 2024-04-29
Michael Brooks active positions
Companies | Position | Start | End |
---|---|---|---|
EDESA BIOTECH, INC. | President | 2019-06-06 | - |
Corporate Officer/Principal | 2015-08-31 | 2018-12-31 |
Career history of Michael Brooks
Former positions of Michael Brooks
Companies | Position | Start | End |
---|---|---|---|
CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 2009-12-31 | 2014-12-31 |
Edesa Biotech Research, Inc. | Corporate Officer/Principal | 2014-12-31 | - |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | President | 2014-12-31 | - |
Training of Michael Brooks
Rotman School of Management | Masters Business Admin |
University of Toronto | Doctorate Degree |
Statistics
International
Canada | 7 |
Operational
Corporate Officer/Principal | 3 |
President | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
CIPHER PHARMACEUTICALS INC. | Health Technology |
EDESA BIOTECH, INC. | Health Technology |
Private companies | 2 |
---|---|
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | Health Technology |
Edesa Biotech Research, Inc. |
- Stock Market
- Insiders
- Michael Brooks
- Experience